Novartis AG Changes In Equity
Novartis AG (NVSEF) reported Changes In Equity of -$15.53 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:ChangesInEquity · last filed 2026-02-04
- Novartis AG changes in equity for the quarter ending 2025-06-30 was -$2.41B.
- Novartis AG changes in equity for the quarter ending 2024-06-30 was -$1.30B.
- Novartis AG changes in equity for the quarter ending 2023-06-30 was -$2.75B, a 1501.53% decline year-over-year.
- Novartis AG changes in equity for the quarter ending 2022-06-30 was $196.00M.
| Period end | Changes In Equity 3 month | Changes In Equity 6 month | Changes In Equity 12 month |
|---|---|---|---|
| 2025-12-31 | -$15.53B 20-F · filed 2026-02-04 | ||
| 2025-06-30 | -$2.41B 6-K · filed 2025-07-17 | -$12.73B 6-K · filed 2025-07-17 | |
| 2024-12-31 | -$15.15B 20-F · filed 2026-02-04 | ||
| 2024-06-30 | -$1.30B 6-K · filed 2025-07-17 | -$9.72B 6-K · filed 2025-07-17 | |
| 2023-12-31 | -$28.73B 20-F · filed 2026-02-04 | ||
| 2023-06-30 | -$2.75B 6-K · filed 2024-07-18 | -$12.49B 6-K · filed 2024-07-18 | |
| 2022-12-31 | -$14.51B 20-F · filed 2025-01-31 | ||
| 2022-06-30 | $196.00M 6-K · filed 2023-07-18 | -$9.58B 6-K · filed 2023-07-18 | |
| 2021-12-31 | -$10.37B 20-F · filed 2024-01-31 | ||
| 2021-06-30 | -$582.00M 6-K · filed 2022-07-19 | -$7.84B 6-K · filed 2022-07-19 | |
| 2020-12-31 | -$10.29B 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | $206.00M 6-K · filed 2021-07-21 | -$5.88B 6-K · filed 2021-07-21 | |
| 2019-12-31 | -$34.67B 20-F · filed 2022-02-02 | ||
| 2019-06-30 | -$2.69B 6-K · filed 2020-07-21 | -$35.09B 6-K · filed 2020-07-21 | |
| 2018-12-31 | -$7.80B 20-F · filed 2021-01-26 | ||
| 2018-06-30 | -$941.00M 6-K · filed 2019-07-18 | -$7.33B 6-K · filed 2019-07-18 | |
| 2017-12-31 | -$11.20B 20-F · filed 2020-01-29 | ||
| 2017-06-30 | -$1.55B 6-K · filed 2018-07-18 | -$11.56B 6-K · filed 2018-07-18 | |
| 2016-12-31 | -$6.60B 20-F · filed 2019-01-30 | ||
| 2015-12-31 | -$9.71B 6-K · filed 2018-01-24 |